Clinical Trial Update: GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a GLP-1 receptor agonist for glucose intolerance in cystic fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Diabetes Mellitus
• Impaired Glucose Tolerance
• Pancreatic Insufficiency

Drugs mentioned

• GLP-1 receptor agonist (unspecified)

Snippet

Sponsor: University of Pennsylvania | Conditions: Cystic Fibrosis, Pancreatic Insufficiency | Phase 2 | Status: RECRUITING